Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
OVIDCompany Name
OVID THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQOVID THERAPEUTICS INC - Enterprise Value over EBITDA Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
OVID - EV/EBITDA Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | Enterprise Value | Enterprise Value over EBITDA |
|---|---|---|---|
| 6/30/2025 | $ -36.47M | $ 44.76M | 0 |
| 3/31/2025 | $ -23.24M | $ 11.7M | 0 |
| 12/31/2024 | $ -24.72M | $ 21.35M | 0 |
| 9/30/2024 | $ -30.83M | $ 87.15M | 0 |
| 6/30/2024 | $ -28.12M | $ 47.05M | 0 |
| 3/31/2024 | $ -49.08M | $ 242.15M | 0 |
| 12/31/2023 | $ -50.74M | $ 234.82M | 0 |
| 9/30/2023 | $ -46.89M | $ 209.26M | 0 |
| 6/30/2023 | $ -47.59M | $ 189.89M | 0 |
| 3/31/2023 | $ -49.71M | $ 207.51M | 0 |
Key Performance Insights, Last 5 Years
- OVID THERAPEUTICS INC's latest trailing twelve months (TTM) EV/EBITDA stands at 0.
- Over the past 5 years, OVID THERAPEUTICS INC's average EV/EBITDA has been 0.29.
- The median EV/EBITDA for OVID THERAPEUTICS INC during this period was 0.28
- OVID THERAPEUTICS INC reached its highest EV/EBITDA over the past 5 years at 0.34.
- The lowest EV/EBITDA recorded by OVID THERAPEUTICS INC in the same timeframe 0.25
Similar metrics to EV/EBITDA:
- Enterprise Value over EBIT - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
- Enterprise Value - [Calculation] Enterprise value (EV) refers to the total value of a business and is frequently used as a more elaborate substitute for market capitalization. EV is calculated as a company's [MarketCap] plus its [Debt] minus cash and cash equivalents [CashnEq].
- Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) - [Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
Definition of Enterprise Value over EBITDA
[Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].EV / EBITDA
(=) EV/EBITDA EV/EBITDA for OVID THERAPEUTICS INC is calculated as follows: EV [ $ 296.28M ] / EBITDA [ $ -75.7M ]
(=) EV/EBITDA [ 0 ] OVID - Enterprise Value over EBITDA, Last 5 years
0.25
Minimum
Dec 31, 2021
0.34
Maximum
Jun 30, 2021
0.29
Average
0.28
Median
EV/EBITDA Benchmark AnalysisMarket
The chart above depicts the distribution of EV/EBITDA for companies in the Total Stock Market. The average EV/EBITDA of the companies is 13.49 with a standard deviation of 7.65.
The following table provides additional summary stats:
EV/EBITDA in the Market:
| filtered constituents | 2.43K |
|---|---|
| min | 0.01 |
| max | 40.82 |
| average | 13.49 |
| median | 11.75 |
| std | 7.65 |